Viewing Study NCT01413451


Ignite Creation Date: 2025-12-24 @ 11:43 PM
Ignite Modification Date: 2026-05-17 @ 4:09 PM
Study NCT ID: NCT01413451
Status: TERMINATED
Last Update Posted: 2019-12-17
First Post: 2011-08-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Amatuximab for High Mesothelin Cancers
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Pancreatic Ductal View
None Mesothelioma View
None Ovarian Neoplasms View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Monoclonal IgG Antibody View
None Biodistribution View
None Pharmacokinetics View
None HACA View
None Safety View
None Mesothelioma View
None Ovarian Cancer View
None Pancreatic Duct Cancer View
None Non-Small Cell Lung Cancer View